Status: Recruiting
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.
Participants needed: 5,000
Trial details
Age: 0-99Biological sex: AllType: ObservationalSponsor: The Lymphoma Academic Research OrganisationUpdated: Mar 4, 2026Locations: 36Duration: 15 Years
Eligibility criteria
Patient treated with CAR-T from 1 July 2018 under temporary authorization (ATU)... [+5]